Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitazoxanide vs Rifaximin in IBS-D
NCT05453916Phase 2Withdrawn
- Sponsor
- Sadat City University
- Start
- Jul 2022
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nitazoxanide in Irritable bowel syndrome with diarrhea (IBS-D), sponsored by Sadat City University. Planned start Jul 2022; status: withdrawn.
02
Drugs
nitazoxanide
03
Conditions
Irritable bowel syndrome with diarrhea (IBS-D)
Beyond the preview
Go deeper on NCT05453916.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05453916.